Screener
10x Genomics, Inc. TXG Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: 10x Genomics, Inc.’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054491
FAQ
- What is 10x Genomics, Inc.'s accounts payable?
- 10x Genomics, Inc. (TXG) reported accounts payable of $20.69M in Q2 2026.
- How has 10x Genomics, Inc.'s accounts payable changed year-over-year?
- 10x Genomics, Inc.'s accounts payable increased by 29.8% year-over-year, from $15.94M to $20.69M.
- What is the long-term trend for 10x Genomics, Inc.'s accounts payable?
- Over 5 years (2020 to 2025), 10x Genomics, Inc.'s accounts payable has grown at a 22.0% compound annual growth rate (CAGR), from $4.71M to $12.73M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about 10x Genomics, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude